Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada

Canadian Journal of Ophthalmology

Volumn 43, Issue 6, 2008, Pages 658-668

  Boucher, Marie Carole ^a   Desroches, Gilles ^b   Garcia Salinas, Raul ^c   Kherani, Amin ^d   Maberley, David ^e   Olivier, Sébastien ^a   Oh, Mila ^f   Stockl, Frank ^g  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f ROYAL VICTORIA HOSPITAL   (Canada)

^g UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

Diabetic retinopathy; Pharmacy; Screening; Telemedicine; Teleophthalmology; Urban population

Indexed keywords

TROPICAMIDE;

ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; HEALTH STATUS; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; OPHTHALMOSCOPY; PHARMACY; PREVENTIVE HEALTH SERVICE; RETINA MACULA DEGENERATION; SCREENING TEST; TELEMEDICINE; TELEOPHTHALMOLOGY; URBAN POPULATION;

EID: 57749193290     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-120     Document Type: Article

References (40)

1. Leiter LA, Barr A, Bélanger A. Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 2001;24:1038-43.
2. Shoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001;108:563-71.
3. Lee SJ, Livingston PM, Harper CA, McCarty CA, Taylor HR, Keefe JE. Compliance with recommendations from a screening programme for diabetic retinopathy. Aust NZ J Ophthalmol 1999;27:187-9.
4. Lee SJ, Sicari C, Harper CA, Livingston PM, McCarty CA, Taylor HR, Keefe JE. Examination compliance and screening for DR: a 2-year follow-up study. Clin Experiment Ophthalmol 2000;28:149-52.
5. Klein R, Klein BEK, Neider NW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a non-mydriatic camera and a standard fundus camera. Ophthalmology 1985;92:485-91.
6. Maberly DA, Koushik A, Cruess AF. Factors associated with missed eye examinations in a cohort with diabetes. Can J Public Health 2002;93:229-32.
7. Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinopathy. Diabetes Care 1999;22:752-5.
8. Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 2005;40:734-42.
9. American Telemedicine Association, Ocular Telehealth Special Interest Group, and the National Institute of Standards and Technology Working Group. Telehealth practice recommendations for diabetic retinopathy. May 2004. Available at: http://www.atmeda.org/ICOT/diabeticretionpathy.FINAL.pdf. Accessed February 16, 2006.
10. National Screening Committee. A National Screening Programme for Sight-Threatening Diabetic Retinopathy. National Electronic Library for Health Diabetes. Available at: http://www.nscretinopathy.org.uk/pages/nsc.asp?ModT= A&Sec=16. Updated 13/2/2006. Accessed February 18, 2006.
11. Boucher MC, Gresset JA, Angioi K, Olivier S. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol 2003;38:557-68.
12. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association Mobile Retinal Screening Group. Diabet Med 1996;13:946-52.
13. Burnier MN Jr. Telemedicine and tele-ophthalmology: part II. Can J Ophthalmol 2003;38:537-8, 541-2.
14. Burnier MN Jr. Telemedicine and tele-ophthalmology. Can J Ophthalmol 2003;38:343,345.
15. Brechner RJ, Cowie CC, Howie LJ, Herman H, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714-8.
16. Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 1999;6:61-72.
17. Baker SB, Vallbona C, Campbell JV, Hamill MB, Goetz B, West MS. Diabetic eye disease detection by primary-care physicians. Diabetes Care 1990;13:908-10.
18. Moss ED, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 1995;4:529-34.
19. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
20. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
21. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991;98:823-33.
22. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-91.
23. Persaud DD, Cockerill R, Pink G, Trope G. Determining Ontario's supply and requirements for ophthalmologists in 2000 and 2005. 1. Methods. Can J Ophthalmol 1999;34:74-81.
24. McCarty CA, Taylor KI, McKay R, Keefe JE. Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol 2001;29:52-8.
25. Statistics Canada: summary tables. 2001. Available at: http://www.statcan.ca/english/Pgdb. Accessed February 19, 2005.
26. Green C, Hoppa RD, Young TK, Blanchard J. Geographic analysis of diabetes prevalence in an urban area. Soc Sci Med 2003;57:551-60.
27. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(suppl. 8):S1-29.
28. Bellan L, Buske L. Ophthalmology human resource projections: Are we headed for a crisis in the next 15 years. Can J Ophthalmol 2007;42:34-8.
29. Taylor HR. Diabetic retinopathy: a public health challenge. Am J Ophthalmol 1997;123:543-5.
30. Advisory Panel. Final Report to the UK National Screening Committee's Working Group on Retinopathy: NHS NSC diabetic retinopathy screening. Available at: http://www.scotland.gov.uk/Publications/2003/07/17638/23077. Accessed October 20, 2008.
31. Campagne de dépistage de la rétinopathie diabétique en Bourgogne. Diabétiques, ce dépistage gratuit peur sauver la vue. Available at: http://bourgognediabete.chez-alice.fr/FADB/retinopathie/ depistage%20retinopathie1.htm. Accessed February 16, 2006.
32. Centre for Chronic Disease Prevention and Control, Population and Public Health Branch, Health Canada. Diabetes in Canada. 2nd ed. Ottawa, Ont.: Health Canada, 2002.
33. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18:963-83.
34. McKay R, McCarty CA, Talylor HR. Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol 2000;84:865-70.
35. NHS Quality Improvement Scotland. Clinical standards: diabetic retinopathy screening. March 2004. Available at: http://www.ndrs.scot.nhs.uk/ Links/Docs/drstandards2004.pdf. Accessed October 20, 2008.
36. O'Leary F, Broadbernt F. NHS National Screening Programme for Diabetic Retinopathy. fact sheet: Who can administer eyedrops? Version 2.0. August 2005. Available at: http://www.mhra.gov.uk/Howweregulate/Medicines/ Availabilityprescribingsellingandsupplyingofmedicines/Frequentlyraisedissues/ Retinalscreening/index.htm. Accessed October 20, 2008.
37. Klein BE, Klein R, Moss SE. Incidence of self reported glaucoma in people with diabetes mellitus. Br J Ophthalmol 1997;81:743-7.
38. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968;65:281-93.
39. Martin JD, Yidegiligne HM. The cost-effectiveness of a retinal photography screening program for preventing diabetic retinopathy in the First Nations diabetic population in British Columbia, Canada. Int J Circumpolar Health 1998;57:379-82.
40. Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 2003;168:160-4.